Ngā hua rapu - Gianluca Trifirõ

Whakamahine hua
  1. 1
    Antipsychotic Drug Use and Community-Acquired Pneumonia

    Antipsychotic Drug Use and Community-Acquired Pneumonia mā Gianluca Trifirõ

    I whakaputaina 2011
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  2. 2
    A New Era of Pharmacovigilance: Future Challenges and Opportunities

    A New Era of Pharmacovigilance: Future Challenges and Opportunities mā Gianluca Trifirõ, Salvatore Crisafulli

    I whakaputaina 2022
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  3. 3
    Antipsychotic use in elderly patients and the risk of pneumonia

    Antipsychotic use in elderly patients and the risk of pneumonia mā Giovanni Gambassi, Janet Sultana, Gianluca Trifirõ

    I whakaputaina 2014
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Editorial
    Tiaki ki tētahi rārangi
    I tiakina i:
  4. 4
    Clinical and economic burden of adverse drug reactions

    Clinical and economic burden of adverse drug reactions mā Janet Sultana, Paola Maria Cutroneo, Gianluca Trifirõ

    I whakaputaina 2013
    Whiwhi kuputuhi katoa
    Revisão
    Tiaki ki tētahi rārangi
    I tiakina i:
  5. 5
    Digital Therapeutics in Perspective: From Regulatory Challenges to Post-Marketing Surveillance

    Digital Therapeutics in Perspective: From Regulatory Challenges to Post-Marketing Surveillance mā Salvatore Crisafulli, Eugenio Santoro, Giuseppe Recchia, Gianluca Trifirõ

    I whakaputaina 2022
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  6. 6
    Potential Role of Anti-interleukin (IL)-6 Drugs in the Treatment of COVID-19: Rationale, Clinical Evidence and Risks

    Potential Role of Anti-interleukin (IL)-6 Drugs in the Treatment of COVID-19: Rationale, Clinical Evidence and Risks mā Salvatore Crisafulli, Valentina Isgrò, Laura La Corte, Fabiola Atzeni, Gianluca Trifirõ

    I whakaputaina 2020
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Revisão
    Tiaki ki tētahi rārangi
    I tiakina i:
  7. 7
    Global epidemiology of Duchenne muscular dystrophy: an updated systematic review and meta-analysis

    Global epidemiology of Duchenne muscular dystrophy: an updated systematic review and meta-analysis mā Salvatore Crisafulli, Janet Sultana, Andrea Fontana, Francesco Salvo, Sonia Messina, Gianluca Trifirò

    I whakaputaina 2020
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Revisão
    Tiaki ki tētahi rārangi
    I tiakina i:
  8. 8
    Challenges for Drug Repurposing in the COVID-19 Pandemic Era

    Challenges for Drug Repurposing in the COVID-19 Pandemic Era mā Janet Sultana, Salvatore Crisafulli, Flic Gabbay, Elizabeth Lynn, Saad Shakir, Gianluca Trifirõ

    I whakaputaina 2020
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Revisão
    Tiaki ki tētahi rārangi
    I tiakina i:
  9. 9
    Azithromycin in COVID-19 Patients: Pharmacological Mechanism, Clinical Evidence and Prescribing Guidelines

    Azithromycin in COVID-19 Patients: Pharmacological Mechanism, Clinical Evidence and Prescribing Guidelines mā Janet Sultana, Paola Maria Cutroneo, Salvatore Crisafulli, Gabriele Puglisi, Gaetano Caramori, Gianluca Trifirõ

    I whakaputaina 2020
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Revisão
    Tiaki ki tētahi rārangi
    I tiakina i:
  10. 10
    Impact of Disease-Modifying Antirheumatic Drugs on Cognitive Function in Older Adults with Rheumatoid Arthritis

    Impact of Disease-Modifying Antirheumatic Drugs on Cognitive Function in Older Adults with Rheumatoid Arthritis mā Shafie Fazel, Massimo Carollo, Lisanne Tap, Andrea Spini, Gianluca Trifirõ, Francesco Mattace‐Raso

    I whakaputaina 2025
    Whiwhi kuputuhi katoa
    Revisão
    Tiaki ki tētahi rārangi
    I tiakina i:
  11. 11
    Kidney Disease in Diabetic Patients: From Pathophysiology to Pharmacological Aspects with a Focus on Therapeutic Inertia

    Kidney Disease in Diabetic Patients: From Pathophysiology to Pharmacological Aspects with a Focus on Therapeutic Inertia mā Guido Gembillo, Ylenia Ingrasciotta, Salvatore Crisafulli, Nicoletta Luxi, Rossella Siligato, Domenico Santoro, Gianluca Trifirõ

    I whakaputaina 2021
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Revisão
    Tiaki ki tētahi rārangi
    I tiakina i:
  12. 12
    Psoriasis and psoriasiform reactions secondary to immune checkpoint inhibitors

    Psoriasis and psoriasiform reactions secondary to immune checkpoint inhibitors mā Paola Maria Cutroneo, Ylenia Ingrasciotta, Valentina Isgrò, Emmanuele Venanzi Rullo, Massimiliano Berretta, Francesco Fiorica, Gianluca Trifirõ, Claudio Guarneri

    I whakaputaina 2021
    Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  13. 13
    Post-Marketing Surveillance of CAR-T-Cell Therapies: Analysis of the FDA Adverse Event Reporting System (FAERS) Database

    Post-Marketing Surveillance of CAR-T-Cell Therapies: Analysis of the FDA Adverse Event Reporting System (FAERS) Database mā Michele Fusaroli, Valentina Isgrò, Paola Maria Cutroneo, Carmen Ferrajolo, Valentina Cirillo, Francesca Del Bufalo, Emanuel Raschi, Elisabetta Poluzzi, Gianluca Trifirõ

    I whakaputaina 2022
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  14. 14
    The EU-ADR corpus: Annotated drugs, diseases, targets, and their relationships

    The EU-ADR corpus: Annotated drugs, diseases, targets, and their relationships mā Erik M. van Mulligen, Annie Fourrier‐Réglat, David Gurwitz, Mariam Molokhia, Ainhoa Nieto, Gianluca Trifirõ, Jan A. Kors, Laura I. Furlong

    I whakaputaina 2012
    Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  15. 15
    Prescribing patterns of antiepileptic drugs in Italy: a nationwide population‐based study in the years 2000–2005

    Prescribing patterns of antiepileptic drugs in Italy: a nationwide population‐based study in the years 2000–2005 mā Rodolfo Savica, Ettore Beghi, Giampiero Mazzaglia, Francesco Innocenti, Ovidio Brignoli, Claudio Cricelli, Achille P. Caputi, Rossella Musolino, Edoardo Spina, Gianluca Trifirõ

    I whakaputaina 2007
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  16. 16
    Safety of Biological Therapies for Severe Asthma: An Analysis of Suspected Adverse Reactions Reported in the WHO Pharmacovigilance Database

    Safety of Biological Therapies for Severe Asthma: An Analysis of Suspected Adverse Reactions Reported in the WHO Pharmacovigilance Database mā Paola Maria Cutroneo, Elena Arzenton, Fabiana Furci, Fabio Scapini, Maria Bulzomì, Nicoletta Luxi, Marco Caminati, Gianenrico Senna, Ugo Moretti, Gianluca Trifirõ

    I whakaputaina 2024
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  17. 17
    Different Strategies to Execute Multi‐Database Studies for Medicines Surveillance in Real‐World Setting: A Reflection on the European Model

    Different Strategies to Execute Multi‐Database Studies for Medicines Surveillance in Real‐World Setting: A Reflection on the European Model mā Rosa Gini, Miriam Sturkenboom, Janet Sultana, Alison Cave, Annalisa Landi, Alexandra Păcurariu, Giuseppe Roberto, Tania Schink, Gianmario Candore, Jim Slattery, Gianluca Trifirõ

    I whakaputaina 2020
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Revisão
    Tiaki ki tētahi rārangi
    I tiakina i:
  18. 18
    Safety of direct oral anticoagulants reversal agents in older patients: an analysis of individual case safety reports of adverse drug reaction from VigiBase®

    Safety of direct oral anticoagulants reversal agents in older patients: an analysis of individual case safety reports of adverse drug reaction from VigiBase® mā Giada Crescioli, Niccolò Lombardi, Elena Arzenton, Nicoletta Luxi, Stefano Fumagalli, Roberto Bonaiuti, Costanza Cacini, Guido Mannaioni, Gianluca Trifirõ, Ugo Moretti, Alfredo Vannacci

    I whakaputaina 2025
    Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  19. 19
    In search of potential predictors of erythropoiesis-stimulating agents (ESAs) hyporesponsiveness: a population-based study

    In search of potential predictors of erythropoiesis-stimulating agents (ESAs) hyporesponsiveness: a population-based study mā Ylenia, Ingrasciotta, Viviana, Lacava, Ilaria, Marcianò, Francesco, Giorgianni, Giovanni, Tripepi, Graziella, D’ Arrigo, Alessandro, Chinellato, Ugo, Tari Daniele, Domenico, Santoro, Gianluca, Trifirò

    I whakaputaina 2019
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Text
    Tiaki ki tētahi rārangi
    I tiakina i:
  20. 20
    Association of Individual Non-Steroidal Anti-Inflammatory Drugs and Chronic Kidney Disease: A Population-Based Case Control Study

    Association of Individual Non-Steroidal Anti-Inflammatory Drugs and Chronic Kidney Disease: A Population-Based Case Control Study mā Ylenia Ingrasciotta, Janet Sultana, Francesco Giorgianni, Andrea Fontana, Antonio Santangelo, Daniele Ugo Tari, Domenico Santoro, Vincenzo Arcoraci, Margherita Perrotta, Luisa Ibáñez, Gianluca Trifirõ

    I whakaputaina 2015
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:

Ngā utauta rapu: